Market Synopsis, Global Veterinary Pain Management Market is expected to register a CAGR of 6.46% during the assessment period of 2020 to 2027, to reach USD 4,582.8 Million by 2027., With an increasing incidence rate of chronic zoonotic diseases and increasing pet ownership, the demand for pain relief products and devices is increasing. In addition to that, there is an increase in the number of manufacturers and distributors of pain management drugs and devices across the globe, creating enormous growth opportunities for the established players as well as new entrants. , Market Dynamics, The rise in companion animal ownership & large livestock population, rise in pet insurance with a surge in animal health expenditure, and growing prevalence of animal diseases are expected to drive the growth of the global veterinary pain management market. , The rising number of pet owners across the globe is expected to support market growth over the forecast period. For instance, according to the American Society for the Prevention of Cruelty to Animals (ASPCA), around 6.5 million companion animals enter the US animal shelters nationwide each year. Moreover, as stated by the American Pet Products Association 2015 to 2016 (APPA) survey, approximately 44% of all households in the US had a dog, and 35% had a cat. , Global Veterinary Pain Management Market, by Application, 2019 (%) , Source: MRFR Analysis, Segmentation, Global Veterinary Pain Management Market is Segmented Based on Product, Animal Type, Application, and Distribution Channel., The Veterinary Pain Management Market, on the basis of product, has been segmented into medications, and devices. The market, based on medications, has been sub-segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, local anesthetics, A2-adrenergic agonists, muscle relaxants, sedatives, and others. The NSAIDs segment has been further segmente

Market Synopsis

Global Veterinary Pain Management Market is expected to register a CAGR of 6.46% during the assessment period of 2020 to 2027, to reach USD 4,582.8 Million by 2027.

With an increasing incidence rate of chronic zoonotic diseases and increasing pet ownership, the demand for pain relief products and devices is increasing. In addition to that, there is an increase in the number of manufacturers and distributors of pain management drugs and devices across the globe, creating enormous growth opportunities for the established players as well as new entrants.

Market Dynamics

The rise in companion animal ownership & large livestock population, rise in pet insurance with a surge in animal health expenditure, and growing prevalence of animal diseases are expected to drive the growth of the global veterinary pain management market.

The rising number of pet owners across the globe is expected to support market growth over the forecast period. For instance, according to the American Society for the Prevention of Cruelty to Animals (ASPCA), around 6.5 million companion animals enter the US animal shelters nationwide each year. Moreover, as stated by the American Pet Products Association 2015 to 2016 (APPA) survey, approximately 44% of all households in the US had a dog, and 35% had a cat.

Global Veterinary Pain Management Market, by Application, 2019 (%)

Source: MRFR Analysis

Segmentation

Global Veterinary Pain Management Market is Segmented Based on Product, Animal Type, Application, and Distribution Channel.

The Veterinary Pain Management Market, on the basis of product, has been segmented into medications, and devices. The market, based on medications, has been sub-segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, local anesthetics, A2-adrenergic agonists, muscle relaxants, sedatives, and others. The NSAIDs segment has been further segmented into meloxicam, etodolac, and others. In 2019, the nonsteroidal anti-inflammatory drugs segment held the largest share in the global market. This major share attributes to product launches and large preference by veterinary practitioners. The market, based on opioids, has been divided into morphine, codeine, fentanyl, hydromorphone, and others, whereas the market on the basis of local anesthetics has been fragmented into lidocaine, bupivacaine, chloroprocaine, and others. The market, based on A2-adrenergic agonists, has been further segmented into medetomidine and xylazine. The veterinary pain medications market, based on the route of administration, has been further segmented into oral, parenteral, and topical. Moreover, the veterinary pain management market, based on devices, has been bifurcated into laser therapy devices and electromagnetic therapy devices.

The Veterinary Pain Management Market, based on animal type, has been segmented into companion animals and livestock animals. The market, based on companion animals, has been further segmented into dogs, cats, horses, and others. The market, on the basis of livestock animals, has been further divided into cattle, pigs, poultry, and others. The increasing incidence rate of zoonotic diseases, high spending on animal health, and growing pet insurance are major drivers for the growth of the companion animal segment in 2019.

The Global Veterinary Pain Management Market, by application, has been segmented into joint pain, postoperative pain, cancer, and others. The market, based on joint pain, has been further segmented into osteoarthritis and musculoskeletal disorders. In 2019, the joint pain segment held the largest share in the market. A large population of osteoarthritis and new product launches are expected to boost the growth of the market during the forecast period.

The Global Veterinary Pain Management Market, by distribution channel, has been segmented into veterinary hospitals & clinics, pharmacies, and online pharmacies. The veterinary hospitals and clinics held the largest share in 2019 owing to the wide availability of pain medications in these settings.

Asia-Pacific Veterinary Pain Management Market Share, by Country, 2019 (%)

Source: MRFR Analysis

Regional Analysis

Global Veterinary Pain Management Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North American market further divided into the US and Canada. The Americas held the largest market share for veterinary pain management in 2019. This share is attributed to the increasing pet population, new product launches, and the rising number of neurological diseases in the region.

The European veterinary pain management market has been divided into Western Europe and Eastern Europe. The Western Europe veterinary pain management market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe accounts for the second-largest share in the global veterinary pain management market. The high incidence of cancer in animals boosts the growth of the market in European countries. In Italy, according to the Animal Tumor Registry of Genoa, the incidence rate of malignant cancers estimated to be about 185.7/100,000 cases found in dogs.

The Veterinary Pain Management Market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to witness the highest market growth potential over the forecast period due to the growing pet population and key players expanding their presence in this region.

The Middle East & Africa veterinary pain management market is segmented into two major regions, namely the Middle East and Africa. In this region, the Middle East would hold a substantial market share over the assessment period due to developing healthcare infrastructure, booming medical tourism, and gradually increasing adoption of treatment in animals.

Key Players

The Prominent Players in the Global Veterinary Pain Management Market are Ceva (US), Boehringer Ingelheim (Germany), Assisi Animal Health (US), Eltech K-Laser (Italy), Zoetis (US), Elanco (US), Merck Animal Health (US), Bayer AG (Germany), Chanelle Pharma Group (Ireland), Dechra Pharmaceuticals PLC (UK), Norbrook Laboratories (UK), Vetoquinol S.A. (France), and others.

Some of the key strategies followed by players operating in the global veterinary pain management market were FDA approvals, joint ventures, expansions, and collaborations among others.



In June 2019 , Ceva consolidated its investments in Mainland France, specifically in Laval, where it has established its global hub for innovation in the companion animal sector





In October 2018 , Assisi Animal Health introduced the Assisi Loop Lounge, a therapeutic pet bed powered by the Assisi Loop's targeted pulsed electromagnetic field (tPEMF) technology, in collaboration with Sleepypod, a renowned maker of innovative crash-tested pet carriers





In July 2019 , Vetoquinol S.A. announced a plan to reorganize its production facilities in Europe



Market Segmentation

Global Veterinary Pain Management Market, by Product



Medication



NSAIDs



Meloxicam

Etodolac

Others





Opioids



Morphine

Codeine

Fentanyl

Hydromorphone

Others





Local Anesthetics



Lidocaine

Bupivacaine

Chloroprocaine

Others





Αlpha 2-Adrenergic Agonists



Medetomidine

Xylazine

Sedatives

Muscle Relaxants

Others





Route of Administration



Oral

Parenteral

Topical











Devices



Laser Therapy Devices

Electromagnetic Therapy Devices









Global Veterinary Pain Management Market, by Animal Type



Companion Animals



Dogs

Cats

Horses

Others







Livestock Animals



Cattle

Pigs

Poultry

Others









Global Veterinary Pain Management Market, by Application



Joint Pain



Osteoarthritis

Musculoskeletal Disorders







Postoperative Pain



Cancer



Others



Global Veterinary Pain Management Market, by Distribution Channel



Veterinary Hospitals & Clinics



Pharmacies



Online Pharmacies



Global Veterinary Pain Management Market, by Region



Americas



North America



US

Canada





Latin America











Europe



Western Europe



Germany

France

UK

Italy

Spain

Rest of Western Europe





Eastern Europe











Asia-Pacific



Japan

China

India

Australia

South Korea

Rest of Asia-Pacific











Middle East & Africa



Middle East

Africa









Available Additional Customizations



Impact of COVID-19 on Veterinary Pain Management Market



Mega Trends in the Market



Investment Opportunities



Pricing Analysis



Intended Audience



Veterinary hospitals



Pharmaceutical companies



Medical device companies



Contract research organizations



Research & development organizations



Academic institutes



Frequently Asked Questions (FAQ) :